Peripheral neuropathy in adult type 1 Gaucher disease: A 2-year prospective observational study

Marieke Biegstraaten, Eugen Mengel, Laszlo Maródi, Milan Petakov, Claus Niederau, Pilar Giraldo, Derralyn Hughes, Mirando Mrsic, Atul Mehta, Carla E.M. Hollak, Ivo N. Van Schaik

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Type 1 Gaucher disease is currently categorized as non-neuronopathic, although recent studies suggest peripheral neurological manifestations. We report prevalence and incidence data for peripheral neuropathy and associated conditions from a multinational, prospective, longitudinal, observational cohort study in patients with type 1 Gaucher disease, either untreated or receiving enzyme replacement therapy. The primary outcome parameters were the prevalence and incidence of polyneuropathy, evaluated by standardized assessments of neurological symptoms and signs, and electrophysiological studies. All diagnoses of polyneuropathy were adjudicated centrally. Secondary outcome parameters included the prevalence and incidence of mononeuropathy, other neurological or electrophysiological abnormalities not fulfilling the criteria for a mono-or polyneuropathy and general type 1 Gaucher disease symptoms. Furthermore, a literature search was performed to identify all studies reporting on prevalence and incidence of polyneuropathy in the general population. One hundred and three patients were enrolled [median (range) age: 42 (18-75) years; disease duration: 15 (0-56) years; 52 female]; 14 (13.6) were untreated and 89 (86.4) were on enzyme replacement therapy. At baseline, 11 patients [10.7; 95 confidence interval (CI): 5.9-18.3] were diagnosed with sensory motor axonal polyneuropathy. Two (1.9; 95 CI: 0.1-7.2) had a mononeuropathy of the ulnar nerve. The 2-year follow-up period revealed another six cases of polyneuropathy (2.9 per 100 person-years; 95 CI: 1.2-6.3). Patients with polyneuropathy were older than those without (P<0.001). Conditions possibly associated with polyneuropathy were identified in four patients only, being monoclonal gammopathy, vitamin B1 deficiency, folic acid deficiency, type 2 diabetes mellitus, renal insufficiency, alcohol abuse and exposure to toxins related to profession. The 11 cases of polyneuropathy found at baseline were confirmed during follow-up. According to the literature, the prevalence of polyneuropathy in the general population was estimated between 0.09 and 1.3 and the incidence was estimated between 0.0046 and 0.015 per 100 person-years. Thus, we conclude that the prevalence and incidence of polyneuropathy in patients with type 1 Gaucher disease is increased compared with the general population.

Original languageEnglish
Pages (from-to)2909-2919
Number of pages11
JournalBrain
Volume133
Issue number10
DOIs
Publication statusPublished - Oct 2010

Keywords

  • EMG
  • Gaucher disease
  • incidence
  • peripheral neuropathy
  • prevalence

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Peripheral neuropathy in adult type 1 Gaucher disease: A 2-year prospective observational study'. Together they form a unique fingerprint.

  • Cite this

    Biegstraaten, M., Mengel, E., Maródi, L., Petakov, M., Niederau, C., Giraldo, P., Hughes, D., Mrsic, M., Mehta, A., Hollak, C. E. M., & Van Schaik, I. N. (2010). Peripheral neuropathy in adult type 1 Gaucher disease: A 2-year prospective observational study. Brain, 133(10), 2909-2919. https://doi.org/10.1093/brain/awq198